Zhu, Tian, Zhu, Chao, Qiu, Yue, Li, Qian, Yu, Xin, Hao, Guo, Song, Ping, Xu, Jian, Li, Peng, Yin, Ya-ling. (1400). Tertiary butylhydroquinone alleviated liver steatosis and increased cell survival via β-arrestin-2/PI3K/AKT pathway. , 24(10), 1428-1436. doi: 10.22038/ijbms.2021.58156.12924
Tian Tian Zhu; Chao Nan Zhu; Yue Qiu; Qian Shuai Li; Xin Yu; Guo Jie Hao; Ping Song; Jian Xu; Peng Li; Ya-ling Yin. "Tertiary butylhydroquinone alleviated liver steatosis and increased cell survival via β-arrestin-2/PI3K/AKT pathway". , 24, 10, 1400, 1428-1436. doi: 10.22038/ijbms.2021.58156.12924
Zhu, Tian, Zhu, Chao, Qiu, Yue, Li, Qian, Yu, Xin, Hao, Guo, Song, Ping, Xu, Jian, Li, Peng, Yin, Ya-ling. (1400). 'Tertiary butylhydroquinone alleviated liver steatosis and increased cell survival via β-arrestin-2/PI3K/AKT pathway', , 24(10), pp. 1428-1436. doi: 10.22038/ijbms.2021.58156.12924
Zhu, Tian, Zhu, Chao, Qiu, Yue, Li, Qian, Yu, Xin, Hao, Guo, Song, Ping, Xu, Jian, Li, Peng, Yin, Ya-ling. Tertiary butylhydroquinone alleviated liver steatosis and increased cell survival via β-arrestin-2/PI3K/AKT pathway. , 1400; 24(10): 1428-1436. doi: 10.22038/ijbms.2021.58156.12924

Tertiary butylhydroquinone alleviated liver steatosis and increased cell survival via β-arrestin-2/PI3K/AKT pathway

Iranian Journal of Basic Medical Sciences
دوره 24، شماره 10، دی 2021، صفحه 1428-1436    اصل مقاله (957.93 K)
نوع مقاله: Original Article
شناسه دیجیتال (DOI): 10.22038/ijbms.2021.58156.12924
نویسندگان
Tian Tian Zhu* 1، 2؛ Chao Nan Zhu1، 3، 4، 2؛ Yue Qiu1، 2؛ Qian Shuai Li1، 2؛ Xin Yu1، 2؛ Guo Jie Hao1، 2؛ Ping Song1، 2؛ Jian Xu1، 2؛ Peng Li1، 2؛ Ya-ling Yin5
1College of Pharmacy, Xinxiang Medical University, Xinxiang, China
2Xinxiang Key Laboratory of Vascular Remodeling Intervention and Molecular Targeted Therapy Drug Development, Xinxiang, China
3Department of Pharmacy, The first Affiliated Hospital of Xinxiang Medical University, Xinxiang, China
4Henan International Joint Laboratory of Cardiovascular Remodeling and Drug Intervention, Xinxiang, China
5School of Basic Medical Sciences, Xinxiang Medical University, Xinxiang, China, 453003
چکیده
Objective(s): This study aimed to evaluate the effects and the underlying mechanisms of tertiary butylhydroquinone (TBHQ) on diabetic liver steatosis and cell survival.
Materials and Methods: We performed streptozocin injection and used a high-sugar-high-fat diet for mice to develop an animal model of type 2 diabetes mellitus (T2DM). Bodyweight, blood glucose levels, and content of insulin were measured on all of the mice. The liver tissues were observed by hematoxylin-eosin staining. Protein levels of the liver were measured by Western blot analysis in mice. Primary hepatocytes were induced by hypochlorous acid (HClO) and insulin to form insulin resistance (IR). Primary hepatocyte apoptosis was observed by Hoechst staining. The PI3K/AKT signaling pathway and β-arrestin-2 factor were evaluated by Western blot assay.
Results: TBHQ reduced the blood glucose level and content of insulin in serum, increased body weight, and effectively alleviated liver steatosis in diabetic mice. TBHQ significantly up-regulated the expression of p-PI3K, p-AKT, GLUT4, GSK3β, and β-arrestin-2 in the liver of diabetic mice. Cell experiments confirmed that TBHQ increased the survival ability of primary hepatocytes, and TBHQ improved the expression of p-PI3K, p-AKT, GLUT4, and GSK3β by activating β-arrestin-2 in primary hepatocytes.
Conclusion: TBHQ could alleviate liver steatosis and increase cell survival, and the mechanism is due in part to β-arrestin-2 activation.
کلیدواژه‌ها
Insulin resistance؛ Liver steatosis؛ Tertiary butylhydroquinone؛ Type 2 diabetes mellitus؛ β-arrestin-2
مراجع
آمار
تعداد مشاهده مقاله: 1,218
تعداد دریافت فایل اصل مقاله: 692
دانشگاه علوم پزشکی مشهد
آمار
تعداد نشریات29
تعداد شماره‌ها2,324
تعداد مقالات24,861
تعداد مشاهده مقاله82,768,048
تعداد دریافت فایل اصل مقاله45,833,822
اخبار نشریات